Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim, Sohee Jeon, Lena F. Burbulla, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 11, pp. 1972-1988
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Role of cholesterol and sphingolipids in brain development and neurological diseases
Ghulam Hussain, Jing Wang, Azhar Rasul, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 291
The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 200
Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
Soojin Kim, Yvette C. Wong, Fanding Gao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
G. Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 34-44
Closed Access | Times Cited: 93
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
Fabio Blandini, Roberto Cilia, Silvia Cerri, et al.
Movement Disorders (2018) Vol. 34, Iss. 1, pp. 9-21
Closed Access | Times Cited: 91
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1406-1422
Open Access | Times Cited: 90
Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
Raja Elizabeth Estes, Bernice Lin, Arnav Khera, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 57
Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
Alba Navarro-Romero, Irene Fernández-González, Jordi Riera, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Satra Nim, Darren M. O’Hara, Carles Corbi‐Verge, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
Elisa Menozzi, Marco Toffoli, Anthony H.V. Schapira
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108419-108419
Open Access | Times Cited: 24
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Marie-Laure Arotçarena, Margaux Teil, Benjamin Dehay
Cells (2019) Vol. 8, Iss. 6, pp. 565-565
Open Access | Times Cited: 67
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
Stefanie Smolders, Christine Van Broeckhoven
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
Shaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Acta Neuropathologica (2020) Vol. 139, Iss. 6, pp. 1001-1024
Open Access | Times Cited: 57
Lyso-glycosphingolipids: presence and consequences
Marco van Eijk, Maria J. Ferraz, Rolf G. Boot, et al.
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 565-578
Open Access | Times Cited: 54
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
Antía Custodia, Marta Aramburu-Núñez, Clara Correa‐Paz, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 945-945
Open Access | Times Cited: 41
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
Novel Approaches Targeting in α-Synuclein for Parkinson's Disease: Current Progress and Future Directions for the Disease-Modifying Therapies
David Baggett, Alex Olson, Mayur Parmar
Brain Disorders (2024), pp. 100163-100163
Open Access | Times Cited: 7
Lysosomal storage diseases: current therapies and future alternatives
Andrés Felipe Leal, Ángela J. Espejo, Oscar F. Sánchez, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 7, pp. 931-946
Closed Access | Times Cited: 48
The Endo-lysosomal System in Parkinson’s Disease: Expanding the Horizon
Amitha Muraleedharan, Benoît Vanderperre
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168140-168140
Open Access | Times Cited: 14
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
Young Eun Huh, Tatiana Usnich, Clemens R. Scherzer, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 3, pp. 261-278
Open Access | Times Cited: 13
Peripheral Upregulation of Parkinson’s Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression
Razvan-Marius Brazdis, Claudia von Zimmermann, Bernd Lenz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3219-3219
Open Access | Times Cited: 5
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
Baoyi Li, Ulf Dettmer
Neurobiology of Disease (2024) Vol. 201, pp. 106646-106646
Open Access | Times Cited: 5
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Lijun Dai, Miao Liu, Ke Wei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top